Menarini Asia-Pacific is part of the world’s largest Italian biopharmaceutical company with a heritage since 1886 and over 17,500 employees in more than 140 countries. Here in Asia-Pacific, Menarini has an established presence in 13 key healthcare markets with over 3,500 sales, marketing and support professionals.

Supported by the Group’s R&D, manufacturing and infrastructure capabilities, Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields including Consumer Health, Dermatology, Allergy/Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology/Specialty Care and Men’s Health.

Menarini has a strong partnering tradition. As companies reprioritize portfolios and seek experienced partners to gain market access in this heterogeneous environment, Menarini is a trusted European partner who can be the gateway for companies that want to tap into the Asia-Pacific growth story.

To spearhead leading edge research and development efforts internationally, Menarini Asia-Pacific established A. Menarini Biomarkers Singapore in 2014 with R&D capabilities to study rare cells and determine the biological significance of distinct subpopulations of cells within a sample. With this knowledge, new diagnostic and therapeutic strategies can be developed to improve patient outcomes and address unmet medical needs.